Company registration number 07846632 (England and Wales)
PETER J D EVANS MEDICAL LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024
PAGES FOR FILING WITH REGISTRAR
PETER J D EVANS MEDICAL LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 7
PETER J D EVANS MEDICAL LTD
BALANCE SHEET
AS AT
30 NOVEMBER 2024
30 November 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
5
9,523
14,725
Investments
6
205,773
211,519
215,296
226,244
Current assets
Debtors
7
66,534
97,511
Cash at bank and in hand
163,830
207,507
230,364
305,018
Creditors: amounts falling due within one year
8
(40,966)
(50,267)
Net current assets
189,398
254,751
Net assets
404,694
480,995
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
404,594
480,895
Total equity
404,694
480,995

The notes on pages 2 to 7 form part of these financial statements.

For the financial year ended 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 6 May 2025 and are signed on its behalf by:
Dr P J D Evans
Mrs C R Evans
Director
Director
Company registration number 07846632 (England and Wales)
PETER J D EVANS MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024
- 2 -
1
Accounting policies
Company information

Peter J D Evans Medical Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 5 St George's Place, Sandwich, Kent, England, CT13 9LW.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. Modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT.

The company recognises revenue from the following major sources:

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

PETER J D EVANS MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2024
1
Accounting policies
(Continued)
- 3 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
10% Straight Line
Plant and equipment
25% Reducing Balance
Fixtures and fittings
25% Reducing Balance
Computers
25% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

PETER J D EVANS MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2024
1
Accounting policies
(Continued)
- 4 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

PETER J D EVANS MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2024
- 5 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
2
2
4
Intangible fixed assets
Goodwill
£
Cost
At 1 December 2023 and 30 November 2024
90,000
Amortisation and impairment
At 1 December 2023 and 30 November 2024
90,000
Carrying amount
At 30 November 2024
-
0
At 30 November 2023
-
0
PETER J D EVANS MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2024
- 6 -
5
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 December 2023
39,486
60,369
99,855
Additions
-
0
1,444
1,444
At 30 November 2024
39,486
61,813
101,299
Depreciation and impairment
At 1 December 2023
35,555
49,573
85,128
Depreciation charged in the year
3,949
2,699
6,648
At 30 November 2024
39,504
52,272
91,776
Carrying amount
At 30 November 2024
(18)
9,541
9,523
At 30 November 2023
3,930
10,795
14,725
6
Fixed asset investments
2024
2023
£
£
Other investments other than loans
205,773
211,519
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 December 2023
211,519
Valuation changes
(5,746)
At 30 November 2024
205,773
Carrying amount
At 30 November 2024
205,773
At 30 November 2023
211,519
PETER J D EVANS MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2024
- 7 -
7
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
66,534
97,511
8
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
566
3,771
Corporation tax
8,126
16,029
Other taxation and social security
26,081
23,019
Other creditors
6,193
7,448
40,966
50,267
9
Operating lease commitments
As lessee

[Further information as appropriate]

The operating leases represent leases [of XXX] to third parties. The leases are negotiated over terms of [XX-YY] years and rentals are fixed for [XX-YY] years. All leases include a provision for five-yearly upward rent reviews according to prevailing market conditions. There are no options in place for either party to extend the lease terms.

[Further information as appropriate]

2024-11-302023-12-01falsefalsefalse06 May 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityDr P J D EvansMrs C R Evans078466322023-12-012024-11-30078466322024-11-30078466322023-11-3007846632core:LandBuildings2024-11-3007846632core:OtherPropertyPlantEquipment2024-11-3007846632core:LandBuildings2023-11-3007846632core:OtherPropertyPlantEquipment2023-11-3007846632core:ShareCapital2024-11-3007846632core:ShareCapital2023-11-3007846632core:RetainedEarningsAccumulatedLosses2024-11-3007846632core:RetainedEarningsAccumulatedLosses2023-11-3007846632bus:Director12023-12-012024-11-3007846632bus:Director22023-12-012024-11-3007846632core:Goodwill2023-12-012024-11-3007846632core:LeaseholdImprovements2023-12-012024-11-3007846632core:PlantMachinery2023-12-012024-11-3007846632core:FurnitureFittings2023-12-012024-11-3007846632core:ComputerEquipment2023-12-012024-11-30078466322022-12-012023-11-3007846632core:NetGoodwill2023-11-3007846632core:NetGoodwill2024-11-3007846632core:NetGoodwill2023-11-3007846632core:LandBuildings2023-11-3007846632core:OtherPropertyPlantEquipment2023-11-30078466322023-11-3007846632core:LandBuildings2023-12-012024-11-3007846632core:OtherPropertyPlantEquipment2023-12-012024-11-3007846632core:CurrentFinancialInstruments2024-11-3007846632core:CurrentFinancialInstruments2023-11-3007846632bus:PrivateLimitedCompanyLtd2023-12-012024-11-3007846632bus:SmallCompaniesRegimeForAccounts2023-12-012024-11-3007846632bus:FRS1022023-12-012024-11-3007846632bus:AuditExemptWithAccountantsReport2023-12-012024-11-3007846632bus:FullAccounts2023-12-012024-11-30xbrli:purexbrli:sharesiso4217:GBP